Latent proteins LMP1 and LMP2A drive these effects through the upregulation of DNMT1, DNMT3A, and DNMT3B, leading to transcriptional silencing of tumor suppressors (Yau et al., 2014; Scott, 2017; Okano, 2000). This evidence concerns the gene DNMT3B and neoplasm.